However, in hepatocellular carcinoma, PRDX6 was lower expressed in the tumor than the non-tumor tissues and its decrease was associated with poor prognosis 25, indicating its anti-tumor function in liver cancer. This evidence concerns the gene PRDX6 and hepatocellular carcinoma.